GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NeoImmuneTech Inc (XKRX:950220) » Definitions » Float Percentage Of Total Shares Outstanding

NeoImmuneTech (XKRX:950220) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 28, 2024)


View and export this data going back to 2021. Start your Free Trial

What is NeoImmuneTech Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, NeoImmuneTech's float shares is 0.00 Mil. NeoImmuneTech's total shares outstanding is 19.77 Mil. NeoImmuneTech's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, NeoImmuneTech's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, NeoImmuneTech's Institutional Ownership is 0.21%.

NeoImmuneTech Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

NeoImmuneTech's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/19.77
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeoImmuneTech (XKRX:950220) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NeoImmuneTech Inc (XKRX:950220) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
XKRX:215380 XKRX:322970 XKRX:343090 XKRX:283100 XKRX:446440 XKRX:072520 XKRX:251280 XKRX:179530 XKRX:344860 XKRX:208340 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
2400 Research Boulevard, Suite 250, Rockville, MD, USA, 20850
Website
http://www.neoimmunetech.com
NeoImmuneTech Inc is a clinical-stage T cell-focused biotech company dedicated to the discovery and development of novel immuno-therapeutics. Its lead asset NT-I7 is the clinical stage IL-7, which enhances the body's immune function to address key resistance mechanisms in Immuno-Oncology and deadly infectious diseases.

NeoImmuneTech (XKRX:950220) Headlines

No Headlines